China SXT Pharmaceuticals (SXTC) Accumulated Depreciation & Amortization: 2018-2025
- China SXT Pharmaceuticals' Accumulated Depreciation & Amortization rose 0.09% to $2.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was $8.5 million, marking a year-over-year increase of 7.64%. This contributed to the annual value of $2.4 million for FY2025, which is 0.09% up from last year.
- According to the latest figures from Q1 2025, China SXT Pharmaceuticals' Accumulated Depreciation & Amortization is $2.4 million, which was up 0.09% from $2.4 million recorded in Q1 2024.
- In the past 5 years, China SXT Pharmaceuticals' Accumulated Depreciation & Amortization ranged from a high of $2.4 million in Q1 2025 and a low of $1.5 million during Q1 2021.
- For the 3-year period, China SXT Pharmaceuticals' Accumulated Depreciation & Amortization averaged around $2.3 million, with its median value being $2.4 million (2024).
- Data for China SXT Pharmaceuticals' Accumulated Depreciation & Amortization shows a peak YoY skyrocketed of 42.15% (in 2021) over the last 5 years.
- China SXT Pharmaceuticals' Accumulated Depreciation & Amortization (Quarterly) stood at $1.5 million in 2021, then grew by 25.00% to $1.7 million in 2022, then climbed by 5.58% to $1.9 million in 2023, then increased by 25.97% to $2.4 million in 2024, then grew by 0.09% to $2.4 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $2.4 million for Q1 2025, versus $2.4 million for Q1 2024 and $1.9 million for Q1 2023.
